Solara Active Pharma Sciences Ltd Annually Results

Gross Sales

1,288.92

1,443.81

1,268.34

1,616.88

1,321.75

Excise Duty

0

0

0

0

0

Net Sales

1,288.92

1,443.81

1,268.34

1,616.88

1,321.75

Other Operating Income

0

0

0

0

0

Other Income

5.37

22.55

20.02

28.77

27.52

Total Income

1,294.29

1,466.36

1,288.36

1,645.65

1,349.27

Total Expenditure

1,574.27

1,309.92

1,191.86

1,231.01

1,062.31

PBIDT

-279.98

156.44

96.5

414.64

286.96

Interest

105.11

90.06

75.28

84.48

77.89

PBDT

-385.09

66.38

21.22

330.16

209.07

Depreciation

103.33

111.19

112.32

108.66

94.16

Minority Interest Before NP

0

0

0

0

0

Tax

0

-0.09

0.17

38.8

21.08

Deferred Tax

78.54

-22.48

-32.98

-38.65

-20.69

Reported Profit After Tax

-566.96

-22.24

-58.29

221.35

114.52

Minority Interest After NP

0.43

-0.07

-0.14

-0.05

-0.09

Net Profit after Minority Interest

-567.39

-22.17

-58.15

221.4

114.61

Extra-ordinary Items

-159.59

0

-3.48

0

0

Adjusted Profit After Extra-ordinary item

-407.8

-22.17

-54.67

221.4

114.61

EPS (Unit Curr.)

-157.62

-6.16

-16.18

69

44.29

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

70

20

Equity

36

36

36

35.92

26.85

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-21.72

10.83

7.6

25.64

21.71

PBDTM(%)

-29.87

4.59

1.67

20.41

15.81

PATM(%)

-43.98

-1.54

-4.59

13.68

8.66